LBF20107PG01: Difference between revisions

No edit summary
No edit summary
Line 9: Line 9:
|Common Name=&&PROSTAGLANDIN E_1&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&
|Common Name=&&PROSTAGLANDIN E_1&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&
|Melting Point=115-117°C <!--1107-->
|Melting Point=115-117°C <!--1107-->
|Optical=[<FONT FACE="Symbol">a</FONT>]<SUB><FONT SIZE=-1>5</FONT></SUB><SUB><FONT SIZE=-1>7</FONT></SUB><SUB><FONT SIZE=-1>8</FONT></SUB>=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]
|Optical=[alpha]_5 _7 _8 =-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]
|Solubility=DIETHYL ETHER, ETHYL ACETATE <!--1107-->, METHANOL [[Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233|{{RelationTable/GetFirstAuthor|Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233}}]], TETRAHYDROFURAN [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]
|Solubility=DIETHYL ETHER, ETHYL ACETATE <!--1107-->, METHANOL [[Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233|{{RelationTable/GetFirstAuthor|Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233}}]], TETRAHYDROFURAN [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]
|Mass Spectra=METHYL ESTER ; m/e 350, 332, 319, 301, 279 [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]]
|Mass Spectra=METHYL ESTER ; m/e 350, 332, 319, 301, 279 [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]]
|IR Spectra=METHYL ESTER ; <FONT FACE="Symbol">n</FONT> 1726, 1717sh, 1699, 980 cm<SUP><FONT SIZE=-1>-</FONT></SUP><SUP><FONT SIZE=-1>1</FONT></SUP> [[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]
|IR Spectra=METHYL ESTER ; nu 1726, 1717sh, 1699, 980 cm^- ^1 [[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]
|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR(CDCl<SUB><FONT SIZE=-1>3</FONT></SUB>+DMSO-d<SUB><FONT SIZE=-1>6</FONT></SUB>,TMS) : <FONT FACE="Symbol">d</FONT> 5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H)[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]. <SUP><FONT SIZE=-1>1</FONT></SUP><SUP><FONT SIZE=-1>3</FONT></SUP>C-NMR(CHCl<SUB><FONT SIZE=-1>3</FONT></SUB>-CH<SUB><FONT SIZE=-1>3</FONT></SUB>OH, TMS) : <FONT FACE="Symbol">d</FONT> 215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) [[Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515|{{RelationTable/GetFirstAuthor|Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515}}]]
|NMR Spectra=^1 H-NMR(CDCl_3 +DMSO-d_6 ,TMS) : delta 5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H)[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]. ^1 ^3 C-NMR(CHCl_3 -CH_3 OH, TMS) : delta 215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) [[Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515|{{RelationTable/GetFirstAuthor|Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515}}]]
|Source=Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml [[Reference:Bergstrom_S:,Science,1967,157,382|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:,Science,1967,157,382}}]], and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve [[Reference:Horton_EW:,Physiol. Rev.,1969,49,122|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Physiol. Rev.,1969,49,122}}]][[Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111|{{RelationTable/GetFirstAuthor|Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111}}]][[Reference:Horton_EW:,Experientia,1965,21,113|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Experientia,1965,21,113}}]][[Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749}}]][[Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340}}]][[Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165|{{RelationTable/GetFirstAuthor|Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165}}]].
|Source=Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml [[Reference:Bergstrom_S:,Science,1967,157,382|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:,Science,1967,157,382}}]], and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve [[Reference:Horton_EW:,Physiol. Rev.,1969,49,122|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Physiol. Rev.,1969,49,122}}]][[Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111|{{RelationTable/GetFirstAuthor|Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111}}]][[Reference:Horton_EW:,Experientia,1965,21,113|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Experientia,1965,21,113}}]][[Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749}}]][[Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340}}]][[Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165|{{RelationTable/GetFirstAuthor|Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165}}]].
|Chemical Synthesis=[[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]] {{Image200|LBF20107PG01FT0001.gif}}
|Chemical Synthesis=[[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]] {{Image200|LBF20107PG01FT0001.gif}}

Revision as of 14:00, 19 February 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



PROSTAGLANDIN E1
LBF20107PG01.png
Structural Information
7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid / (8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid
  • PROSTAGLANDIN E1
  • 7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid
  • (8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid
PGE1
Formula C20H34O5
Exact Mass 354.240624198
Average Mass 354.48096000000004
SMILES C(CC[C@@H](O)C=C[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)CC
Physicochemical Information
115-117°C
[α]578=-61.6°(C=0.56, TETRAHYDROFURAN) Corey_EJ et al.
DIETHYL ETHER, ETHYL ACETATE , METHANOL Struijk_MCB et al., TETRAHYDROFURAN Corey_EJ et al.
Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml Bergstrom_S , and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve Horton_EW Speroff_L et al. Horton_EW Karim_SM et al. Karim_SM et al. Kirtland_SJ .
Corey_EJ et al.
LBF20107PG01FT0001.gif
Prostagalndin E1 is produced from H1 at almost the same rate of E2 synthesis from H2 by an enzyme of bovine seminal vesicle Ogino_N et al..
Prostaglandin E1 is generally considered as active as E2, and the biological activities of both compounds are compared in references Bergstrom_S et al.. However, platelet aggregation is inhibited by prostaglandin E1 whereas prostaglandin E2 is much less active Bergstrom_S et al..
Spectral Information
Mass Spectra METHYL ESTER ; m/e 350, 332, 319, 301, 279 HambergMet al.
UV Spectra
IR Spectra METHYL ESTER ; ν 1726, 1717sh, 1699, 980 cm-1 HayashiMet al.
NMR Spectra 1H-NMR(CDCl3+DMSO-d6,TMS) : δ 5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H) HayashiMet al.. 13C-NMR(CHCl3-CH3OH, TMS) : δ 215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) LukacsGet al.
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20107PG01 See above. Bergstrom_S 1967
n.a. LBF20107PG01 See above. Bergstrom_S et al. 1968
n.a. LBF20107PG01 See above. Bergstrom_S et al. 1960
n.a. LBF20107PG01 See above. Corey_EJ et al. 1969
n.a. LBF20107PG01 See above. Hamberg_M et al. 1966
n.a. LBF20107PG01 See above. Hayashi_M et al. 1975
n.a. LBF20107PG01 See above. Horton_EW 1965
n.a. LBF20107PG01 See above. Horton_EW 1969
n.a. LBF20107PG01 See above. Horton_EW et al. 1966
n.a. LBF20107PG01 See above. Karim_SM et al. 1968
n.a. LBF20107PG01 See above. Karim_SM et al. 1967
n.a. LBF20107PG01 See above. Kirtland_SJ 1988
n.a. LBF20107PG01 See above. Lukacs_G et al. 1973
n.a. LBF20107PG01 See above. Ogino_N et al. 1977
n.a. LBF20107PG01 See above. Speroff_L et al. 1970
n.a. LBF20107PG01 See above. Struijk_MCB et al. 1966